From the Editor-in-Chief
More basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
How can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
Putting the Immune System in Overdrive | Weighty Matters | A Blood Test for Cancer | Melanoma Risk Increased in Some Lymphoma Survivors | Aspirin Recommended to Reduce Colorectal Cancer Risk | Fine-Tuning Treatments for Triple-Negative Breast Cancer | Don't Get Burned
Your Cancer Guide
Complementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
Caregiving With Confidence
Follow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
Pain is no gain for patients during or after cancer treatment.
by Sue Rochman
A metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
What's The Beef? | Less Stress
Cancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
When a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
Give patients and their families a break from cancer.
by Maria Wolf
Colleen Bokor, Dana Stewart, Brittany Avin.
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA approves targeted radiotherapy for neuroendocrine tumors.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR